Thomas, Mayer & Associés (TMA) advised the biotech firm O&O mdc, an engineering company in ophthalmic medical devices, specialising in Intraoculair Lenses(IOL) and viscoelastic manufacturing, research into new technologies and project development, in the sale of its business to He Vision Group, 何氏眼保健体系, a group of companies specialized in comprehensive eye care system including eye specialists hospital, vision centres, university, research industry centre.
Acquisition of the Anglo-Italian Biotech O&O MDC by the Chinese Group
Cookies are used on this website to improve the user experience and to ensure the efficient functioning of the website.
By using this website, you agree to the use of these cookies please read the Cookies page.
- Recent News: James A. Wolff Contributes to Groundbreaking AI Municipal Use Policy for Berkeley, California
- Recent News: Warshaw Burstein to Participate in Senior Law Day
- Recent News: Perspectives on Elder Law: A Senior Law Day Preview
- Recent News: Law as an Instrument of Economic Warfare: The Magnitsky Act and the Pressure on PIX
- Recent News: News from RW Blears LLP - Winner of UKBAA Award - Best Legal Team